Viewing Study NCT05921760


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-06-09 @ 7:15 PM
Study NCT ID: NCT05921760
Status: COMPLETED
Last Update Posted: 2025-07-15
First Post: 2023-04-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ivosidenib, Nivolumab, and Ipilimumab Combination in Previously Treated Subjects With Nonresectable or Metastatic IDH1 Mutant Cholangiocarcinoma
Sponsor:
Organization: